NCT01691066View on ClinicalTrials.gov

Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 27, 2017

Study Completion Date

February 27, 2017

Conditions
Autism Spectrum Disorders
Interventions
BEHAVIORAL

Infant Toddler Years PRT

Trial Locations (1)

06510

Yale Child Study Center, New Haven

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Yale University

OTHER

NCT01691066 - Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter